Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-16-090112
Filing Date
2016-12-16
Accepted
2016-12-16 18:41:11
Documents
2
Period of Report
2016-12-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 3126
2 bshawpoa.htm EX-24.1 7870
  Complete submission text file 0001140361-16-090112.txt   12402
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Issuer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARDELYX, INC. 34175 ARDENWOOD BLVD, SUITE 200 FREMONT CA 94555
Business Address
Shaw Bryan (Reporting) CIK: 0001691232 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36485 | Film No.: 162057437